Advanced search
Publication Cover
Human Vaccines & Immunotherapeutics Volume 17, 2021 - Issue 11
Submit an article Journal homepage
6,048
Views
3
CrossRef citations to date
0
Altmetric
Letters

Early insight into antibody-dependent enhancement after SARS-CoV-2 mRNA vaccination

Amal Hasana Department of Immunology and Microbiology, Research Division, Dasman Diabetes Institute, Kuwait City, KuwaitCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-1793-7794View further author information
ORCID Icon,
Mohammad R. Al-Mullab Department of Computing Sciences and Engineering, Kuwait University, Kuwait City, KuwaitView further author information
,
Jehad Abubakerc Department of Biochemistry and Molecular Biology, Research Division, Dasman Diabetes Institute, Kuwait City, KuwaitView further author information
&
Fahd Al-Mullad Department of Genetics and Bioinformatics; Functional Genomics, Research Division, Dasman Diabetes Institute, Kuwait City, KuwaitView further author information
Pages 4121-4125 | Received 20 Jun 2021, Accepted 14 Aug 2021, Published online: 20 Sep 2021

References

  • Sahin U, Muik A, Derhovanessian E, Vogler I, Kranz LM, Vormehr M, Baum A, Pascal K, Quandt J, Maurus D, et al. COVID-19 vaccine BNT162b1 elicits human antibody and T H 1 T cell responses. Nature. 2020;586:594-599. doi:10.1038/s41586-020-2814-7
  • Baden LR, El Sahly HM, Essink B, Kotloff K, Frey S, Novak R, Diemert D, Spector SA, Rouphael N, Creech CB, et al. Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine. N Engl J Med. 2021;384:403-416. doi:10.1056/NEJMoa2035389
  • Voysey M, Clemens SAC, Madhi SA, Weckx LY, Folegatti PM, Aley PK, Angus B, Baillie VL, Barnabas SL, Bhorat QE, et al. Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK. Lancet. 2021;397:99–111
  • World Health Organization. COVID-19 vaccine tracker and landscape; 2021 Jul 16 [accessed 2021 July 24]. https://www.who.int/publications/m/item/draft-landscape-of-covid-19-candidate-vaccines.
  • World Health Organization. Coronavirus disease (COVID-19) pandemic. [accessed 2021 July 24]. https://www.who.int/emergencies/diseases/novel-coronavirus-2019.
  • Heath PT, Galiza EP, Baxter DN, Boffito M, Browne D, Burns F, Chadwick DR, Clark R, Cosgrove C, Galloway J, et al. Safety and efficacy of NVX-CoV2373 Covid-19 vaccine. N Engl J Med. 2021. doi:10.1056/NEJMoa2107659.
  • Lambert PH, Ambrosino DM, Andersen SR, Baric RS, Black SB, Chen RT, Dekker CL, Didierlaurent AM, Graham BS, Martin SD, et al. Consensus summary report for CEPI/BC March 12- 13, 2020 meeting: assessment of risk of disease enhancement with COVID-19 vaccines. Vaccine. 2020;38(31):4783–91. doi:10.1016/j.vaccine.2020.05.064.
  • Greaney AJ, Loes AN, Crawford KHD, Starr TN, Malone KD, Chu HY, Bloom JD. Greaney AJ, Loes AN, Crawford KHD, Starr TN, Malone KD, Chu HY, Bloom JD. Comprehensive mapping of mutations in the SARS-CoV-2 receptor-binding domain that affect recognition by polyclonal human plasma antibodies. Cell Host & Microbe. 2021;29(3):463-476.e6. doi:10.1016/j.chom.2021.02.003.
  • Public Health England. SARS-CoV-2 variants of concern and variants under investigation in England. Technical briefing 18. [online] Gov.uk; 2021 Jul 9 [accessed 2021 July 24]. https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1001358/Variants_of_Concern_VOC_Technical_Briefing_18.pdf.
  • Seow J, Graham C, Merrick B, Acors S, Pickering S, Steel KJA, Hemmings O, O’Byrne A, Kouphou N, Galao RP, et al. Longitudinal observation and decline of neutralizing antibody responses in the three months following SARS-CoV-2 infection in humans. Nat Microbiol. 2020. doi:10.1038/s41564-020-00813-8.
  • Tetro JA. Is COVID-19 receiving ADE from other coronaviruses? Microbes Infect. 2020;22(2):72–73. doi:10.1016/j.micinf.2020.02.006.
  • Ricke DO. Two different antibody-dependent enhancement (ADE) risks for SARS-CoV-2 antibodies. Front Immunol. 2021;12:640093. doi:10.3389/fimmu.2021.640093.
  • Liu L, Wei Q, Lin Q, Fang J, Wang H, Kwok H, Tang H, Nishiura K, Peng J, Tan Z, et al. Anti-spike IgG causes severe acute lung injury by skewing macrophage responses during acute SARS-CoV infection. JCI Insight. 2019;4:4. doi:10.1172/jci.insight.123158.
  • Tang F, Quan Y, Xin Z-T, Wrammert J, Ma M-J, Lv H, Wang T-B, Yang H, Richardus JH, Liu W, et al. Lack of peripheral memory B cell responses in recovered patients with severe acute respiratory syndrome: a six-year follow-up study. J Immunol. 2011;186(12):7264–68. doi:10.4049/jimmunol.0903490.
  • Peng H, Yang LT, Wang LY, Li J, Huang J, Lu Z-Q, Koup RA, Bailer RT, Wu C-Y. Long-lived memory T lymphocyte responses against SARS coronavirus nucleocapsid protein in SARS-recovered patients. Virology. 2006;351(2):466–75. doi:10.1016/j.virol.2006.03.036.
  • Ferretti AP, Kula T, Wang Y, Nguyen DMV, Weinheimer A, Dunlap GS, Xu Q, Nabilsi N, Perullo CR, Cristofaro AW, et al. Unbiased screens show CD8+ T cells of COVID-19 patients recognize shared epitopes in SARS-CoV-2 that largely reside outside the spike protein. Immunity. 2020;53(5):1095–107 e1093. doi:10.1016/j.immuni.2020.10.006.
  • Corbett KS, Edwards DK, Leist SR, Abiona OM, Boyoglu-Barnum S, Gillespie RA, Himansu S, Schäfer A, Ziwawo CT, DiPiazza AT, et al. SARS-CoV-2 mRNA vaccine design enabled by prototype pathogen preparedness. Nature. 2020;586(7830):567–71. doi:10.1038/s41586-020-2622-0.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.